Showing 621 - 630 of 802 for "Intellectual%20property" with applied filters
04 January 2024 by
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
04 December 2023 by
LexOrbis is delighted to announce the opening of its new office in Chennai, India.
13 November 2023 by
10 November 2023 | New Delhi: Shardul Amarchand Mangaldas advised Ring Plus Aqua Limited (“RPAL”) on the strategic acquisition of 59.25% stake in Maini Precision Products Limited (“MPPL”), an entity engaged in the business of manufacturing
30 October 2023 by
Section 3(d) of the Indian Patents Act, 1970 was never so controversial till the insertion of an amendment in 2005, which states that “the mere discovery of a new form of a known substance which does not result in the enhancement of the known efficacy of that substance".
16 October 2023 by
With increasing awareness of securing intellectual property rights and deriving value from them, the commercialisation of patents is an important aspect.
18 September 2023 by
Onshore Transactions Continued their Upward Trend, the Biomedical Sector Remained the Most Popular Investment Destination
15 September 2023 by
From January 2023 to now, AnJie Broad has recruited Mr. Keyu CAO, Mr. Zhining Wang, Mr. Mingqing Zhao, Mr. Kevin TSEN, Ms. Yolanda ZHANG, Ms. Yanyan DENG, Mr. Heng KUANG, Ms. Xueping WEI, Mr. Mark YANG, Mr. Min DING, to join the Firm as partners, and has also internally promoted Ms. Shanshan WU, Ms. Kaiying XU, Ms. Yue MA, Ms. Jingjing CAI, Mr. Xingchao HUANG, Mr. Danyang XIANG to become partners.
21 August 2023 by
India has recently witnessed a significant growth in patent filings, including national phase application filings through the Patent Cooperation Treaty (“PCT”) route.
03 August 2023 by
In India, the protection of plant varieties is outside the purview of the patent system.
11 July 2023 by
RNA molecules have been utilized as therapeutic and research tools for more than two decades, with the usage ranging from in vitro transcribed (IVT) mRNA, small interference RNA (siRNA), RNA aptamers, riboswitches, and antisense RNA to the recently developed mRNA vaccines.
